Acadian Asset Management LLC Regeneron Pharmaceuticals, Inc. Transaction History

Acadian Asset Management LLC

  • $32.2 Billion
  • Q3 2024

A detailed history of Acadian Asset Management LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Acadian Asset Management LLC holds 67,289 shares of REGN stock, worth $48.1 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
67,289
Previous 72,830 7.61%
Holding current value
$48.1 Million
Previous $76.5 Million 7.59%
% of portfolio
0.22%
Previous 0.24%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$1024.09 - $1201.76 $5.67 Million - $6.66 Million
-5,541 Reduced 7.61%
67,289 $70.7 Million
Q2 2024

Aug 06, 2024
BUY
$883.2 - $1071.19 $9.44 Million - $11.4 Million
10,689 Added 17.2%
72,830 $76.5 Million
Q1 2024

May 10, 2024
BUY
$902.69 - $993.35 $15.2 Million - $16.7 Million
16,856 Added 37.22%
62,141 $59.8 Million
Q4 2023

Feb 13, 2024
SELL
$775.18 - $881.7 $20.2 Million - $22.9 Million
-26,007 Reduced 36.48%
45,285 $39.7 Million
Q3 2023

Nov 13, 2023
SELL
$692.45 - $844.37 $7.47 Million - $9.11 Million
-10,784 Reduced 13.14%
71,292 $58.6 Million
Q2 2023

Aug 07, 2023
SELL
$700.03 - $830.35 $14.7 Million - $17.4 Million
-20,953 Reduced 20.34%
82,076 $58.9 Million
Q1 2023

May 11, 2023
SELL
$680.49 - $826.97 $66.2 Million - $80.5 Million
-97,354 Reduced 48.58%
103,029 $84.6 Million
Q4 2022

Feb 14, 2023
SELL
$705.89 - $766.39 $42.8 Million - $46.5 Million
-60,612 Reduced 23.22%
200,383 $145 Million
Q3 2022

Nov 14, 2022
SELL
$573.97 - $724.32 $56.5 Million - $71.3 Million
-98,420 Reduced 27.38%
260,995 $180 Million
Q3 2022

Nov 14, 2022
SELL
$573.97 - $724.32 $56.5 Million - $71.3 Million
-98,420 Reduced 27.38%
260,995 $180 Million
Q2 2022

Aug 09, 2022
SELL
$548.35 - $738.84 $38.3 Million - $51.6 Million
-69,783 Reduced 16.26%
359,415 $212 Million
Q1 2022

May 12, 2022
SELL
$595.12 - $698.43 $13.7 Million - $16.1 Million
-22,995 Reduced 5.09%
429,198 $300 Million
Q4 2021

Feb 10, 2022
SELL
$543.48 - $670.97 $42 Million - $51.8 Million
-77,272 Reduced 14.59%
452,193 $286 Million
Q3 2021

Nov 12, 2021
BUY
$574.03 - $680.96 $50.4 Million - $59.8 Million
87,815 Added 19.88%
529,465 $320 Million
Q2 2021

Aug 11, 2021
BUY
$472.8 - $558.54 $7.7 Million - $9.09 Million
16,276 Added 3.83%
441,650 $247 Million
Q1 2021

May 11, 2021
BUY
$446.73 - $548.2 $148 Million - $182 Million
331,154 Added 351.47%
425,374 $201 Million
Q4 2020

Feb 11, 2021
SELL
$478.3 - $607.98 $611,745 - $777,606
-1,279 Reduced 1.34%
94,220 $45.5 Million
Q3 2020

Nov 09, 2020
BUY
$544.75 - $658.21 $8.32 Million - $10.1 Million
15,280 Added 19.05%
95,499 $53.5 Million
Q2 2020

Aug 12, 2020
BUY
$493.32 - $643.92 $37.8 Million - $49.4 Million
76,654 Added 2150.18%
80,219 $50 Million
Q1 2020

May 11, 2020
BUY
$336.18 - $494.43 $550,662 - $809,876
1,638 Added 85.0%
3,565 $1.74 Million
Q4 2019

Feb 06, 2020
BUY
$274.13 - $376.51 $275,226 - $378,016
1,004 Added 108.78%
1,927 $724,000
Q3 2019

Nov 07, 2019
SELL
$273.46 - $318.39 $291,234 - $339,085
-1,065 Reduced 53.57%
923 $256,000
Q2 2019

Aug 08, 2019
SELL
$299.6 - $414.82 $849,665 - $1.18 Million
-2,836 Reduced 58.79%
1,988 $622,000
Q1 2019

May 09, 2019
SELL
$372.08 - $439.57 $6.99 Million - $8.26 Million
-18,790 Reduced 79.57%
4,824 $1.98 Million
Q4 2018

Feb 07, 2019
BUY
$335.82 - $403.04 $832,497 - $999,136
2,479 Added 11.73%
23,614 $8.82 Million
Q3 2018

Oct 30, 2018
BUY
$351.14 - $408.51 $6.9 Million - $8.03 Million
19,649 Added 1322.27%
21,135 $8.54 Million
Q2 2018

Jul 24, 2018
BUY
$284.6 - $344.99 $422,915 - $512,655
1,486 New
1,486 $513,000
Q1 2018

Apr 12, 2018
SELL
$315.82 - $393.78 $63,795 - $79,543
-202 Closed
0 $0
Q4 2017

Jan 18, 2018
SELL
$358.63 - $469.95 $93,961 - $123,126
-262 Reduced 56.47%
202 $76,000
Q3 2017

Oct 13, 2017
BUY
$431.38 - $504.0 $200,160 - $233,856
464
464 $208,000

Others Institutions Holding REGN

# of Institutions
1,534
Shares Held
83.6M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.6B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email